RABISIN, ενέσιμο εναιώρημα
RABISIN, ενέσιμο εναιώρημα
Authorised
- RABIES VIRUS
Product identification
Medicine name:
RABISIN, ενέσιμο εναιώρημα
Active substance:
- RABIES VIRUS
Target species:
-
Cattle
-
Dog
-
Sheep
-
Horse
-
Cat
-
Ferret
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
RABIES VIRUS1.00/international unit(s)1.00Vial
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Cattle
- Dog
- Sheep
- Horse
- Cat
- Ferret
-
Intravenous use
- Cattle
- Sheep
- Cat
- Dog
- Horse
- Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Merial
Responsible authority:
- Ministry Of Agriculture Rural Development And Environment
Authorisation number:
- CY00018V
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 26/08/2022
How useful was this page?:
